UniSA researchers develop new test to predict mood disorders
Scientists from the University of South Australia (UniSA) have developed a new test that accurately predicts the mood disorders in people, by measuring levels of a particular protein
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XScientists from the University of South Australia (UniSA) have developed a new test that accurately predicts the mood disorders in people, by measuring levels of a particular protein
Paige has secured $100m in a Series C funding round, led by Casdin Capital and Johnson & Johnson Innovation (JJDC), the strategic venture capital arm of Johnson &
Oxford-based biotechnology firm Perspectum has received the UK’s Medicines & Healthcare products Regulatory Agency (MHRA) approval for CoverScan MD, an MRI-based technology that maps the effects of Covid-19
Bola Technologies, Inc. (Bola AI), a leading provider of Voice-AI technology for healthcare and dental care professionals, announced today a partnership with Henry Schein One to distribute versions
Nucleai (www.Nucleaimd.com), a global provider in pathology-based biomarker discovery, and Debiopharm (www.debiopharm.com), a Swiss-based biopharmaceutical company specializing in drug development, announced that they have entered into a long-term
Novaerus, a WellAir company that delivers clean air solutions to help prevent the spread of infectious outbreaks, announced today that the U.S. Food and Drug Administration (FDA) cleared
Delfi Diagnostics, a developer of blood tests for early cancer detection, has secured $100m investment in a Series A funding round, led by healthcare-focused investment firm OrbiMed. New
GT Molecular, a molecular diagnostics biotech, has introduced two high-sensitive tests for the new variant of SARS-CoV-2 (B.1.1.7), identified in the UK. The company said that its new
JUD care, a leading high-tech enterprise in the field of smart medical and healthcare solutions, has obtained approval from the US Food and Drug Administration (FDA) for the
Nobel Biocare invites dental professionals to join the Mucointegration™ era with the launch of the Xeal and TiUltra surfaces in the United States. These new surfaces are applied